Variant report
Variant | nsv946075 |
---|---|
Chromosome Location | chr1:92694174-92696985 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:12)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:12 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr1:92694281-92694336 | GM20000 | blood: | n/a | n/a |
2 | HEY1 | chr1:92694111-92694517 | K562 | blood: | n/a | n/a |
3 | POLR2A | chr1:92694236-92694534 | GM12878 | blood: | n/a | n/a |
4 | POLR2A | chr1:92694235-92694431 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | POLR2A | chr1:92696941-92696961 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | POLR2A | chr1:92694061-92694472 | GM12891 | blood: | n/a | n/a |
7 | POLR2A | chr1:92694245-92694447 | Hela-S3 | cervix: | n/a | n/a |
8 | POLR2A | chr1:92694064-92694511 | GM12892 | blood: | n/a | n/a |
9 | POLR2A | chr1:92694048-92694543 | GM12892 | blood: | n/a | n/a |
10 | POLR2A | chr1:92694068-92694465 | GM12891 | blood: | n/a | n/a |
11 | POLR2A | chr1:92694051-92694613 | GM12878 | blood: | n/a | n/a |
12 | YY1 | chr1:92695055-92695183 | K562 | blood: | n/a | chr1:92695159-92695167 chr1:92695148-92695170 |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ACTBP12 | TF binding region |
ENSG00000265543 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs186558949 | chr1:92694433-92694434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs532836849 | chr1:92694449-92694450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs575770053 | chr1:92694455-92694456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547724152 | chr1:92694457-92694458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs559305840 | chr1:92694472-92694473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs530063081 | chr1:92694473-92694474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs548245407 | chr1:92694474-92694475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs370699734 | chr1:92694528-92694529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs570148253 | chr1:92694568-92694569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs536802615 | chr1:92694578-92694579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs542897005 | chr1:92694592-92694593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs552348479 | chr1:92694624-92694625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs570598160 | chr1:92694674-92694675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs544744190 | chr1:92694677-92694678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs534905556 | chr1:92694685-92694686 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs553334667 | chr1:92694694-92694695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs375168304 | chr1:92694711-92694712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs35254986 | chr1:92694763-92694764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs535458562 | chr1:92694765-92694766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557055225 | chr1:92694796-92694797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs564034337 | chr1:92695018-92695019 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs529999898 | chr1:92695043-92695044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs548184583 | chr1:92695075-92695076 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs191740743 | chr1:92695087-92695088 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs531027422 | chr1:92695134-92695135 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs552426739 | chr1:92695146-92695147 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs577358424 | chr1:92695151-92695152 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs528634584 | chr1:92695190-92695191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs570606229 | chr1:92695224-92695225 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs534836798 | chr1:92695251-92695252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs183915273 | chr1:92695286-92695287 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs187467936 | chr1:92695290-92695291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs113559985 | chr1:92695316-92695317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs375226455 | chr1:92695318-92695319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs150562222 | chr1:92695353-92695354 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs192891845 | chr1:92695356-92695357 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs12406749 | chr1:92695398-92695399 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs376466599 | chr1:92696941-92696942 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs558174645 | chr1:92696958-92696959 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 22429812 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 17133270 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 16397240 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Prostate cancer | 19156837 | CNVD |
Autism | 17483303 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:92694400-92694800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
2 | chr1:92694600-92694800 | Enhancers | Pancreas | Pancrea |
3 | chr1:92695000-92695400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |